Loews Corp’s Bristol-Myers Squibb BMY Stock Holding History

Loews Corp’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-280,000	Closed	-$16.3M	–	21
2023 Q3	$16.3M	Buy	280,000 +65,000	+30%	+$3.98M	0.16%	10
2023 Q2	$13.7M	Sell	215,000 -25,000	-10%	-$1.68M	0.14%	13
2023 Q1	$16.6M	Buy	240,000 +70,000	+41%	+$4.94M	0.17%	9
2022 Q4	$12.2M	Hold	170,000	–	–	0.11%	13
2022 Q3	$12.1M	Sell	170,000 -75,000	-31%	-$5.44M	0.13%	13
2022 Q2	$18.9M	Sell	245,000 -60,000	-20%	-$4.57M	0.17%	8
2022 Q1	$22.3M	Sell	305,000 -50,000	-14%	-$3.36M	0.18%	6
2021 Q4	$22.1M	Buy	355,000 +5,000	+1%	+$293K	0.2%	8
2021 Q3	$20.7M	Buy	350,000 +20,000	+6%	+$1.32M	0.19%	9
2021 Q2	$22.1M	Sell	330,000 -10,000	-3%	-$652K	0.19%	7
2021 Q1	$21.5M	Buy	340,000 +50,000	+17%	+$3.11M	0.19%	4
2020 Q4	$18M	Buy	290,000 +20,000	+7%	+$1.23M	0.18%	8
2020 Q3	$16.3M	Sell	270,000 -15,000	-5%	-$903K	0.21%	6
2020 Q2	$16.8M	Sell	285,000 -45,500	-14%	-$2.72M	0.2%	6
2020 Q1	$18.4M	Buy	330,500 +70,500	+27%	+$4.31M	0.23%	5
2019 Q4	$16.7M	Sell	260,000 -200,000	-43%	-$11.5M	0.14%	8
2019 Q3	$23.3M	Buy	460,000 +90,000	+24%	+$4.23M	0.18%	5
2019 Q2	$16.8M	Buy	+370,000	New	+$17.2M	0.13%	12

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Loews Corp's BMY Position: Q4 2023 in Review

Loews Corp sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 280,000 shares — an estimated $16.3M sold.

Loews Corp first reported a position in BMY in Q2 2019 and held it in 18 quarters. The position peaked at $23.3M in Q3 2019. 2,365 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Loews Corp reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Loews Corp sold 280,000 Bristol-Myers Squibb shares in Q4 2023, an estimated $16.3M.
Loews Corp first reported a position in Bristol-Myers Squibb in Q2 2019 and held it in 18 quarters.
Loews Corp's Bristol-Myers Squibb position peaked at $23.3M in Q3 2019.
2,365 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Loews Corp's 13F filing for Q4 2023, filed 9 Feb 2024.